🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,254 results for “First” Clear

  1. 2 cycles induction chemotherapy

    First Tracks Biotherapeutics

    Locally Advanced Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  2. 20 mg sildenafil citrate by mouth

    First Tracks Biotherapeutics

    Pulmonary Hypertension

    phase 3 small molecule active

    1 trial

  3. 3-N-butylphthalide

    First Tracks Biotherapeutics

    Multiple System Atrophy

    phase 3 small molecule active

    1 trial

  4. 6-month course of antiandrogen drugs

    First Tracks Biotherapeutics

    Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

    phase 3 small molecule active

    1 trial

  5. A Phase II/III Multicenter Study Evaluating the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Harboring Actionable Somatic Mutations Detected in Blood (BFAST: Blood First Assay Screening Trial)

    Roche Registration Limited

    Advanced or metastatic Non-small cell lung cancer (NSCLC)

    phase 3 other active

    1 trial

  6. AZVUDINE

    First Tracks Biotherapeutics

    Chronic Hepatitis B

    phase 3 small molecule active

    1 trial

  7. Acetazolamide Levamisole

    First Tracks Biotherapeutics

    HCC

    phase 3 small molecule active

    1 trial

  8. Aerobic Exercise

    First Tracks Biotherapeutics

    Primary Hypertension

    phase 3 other active

    1 trial

  9. Alirocumab

    First Tracks Biotherapeutics

    Intracranial Atherosclerosis

    phase 3 small molecule active

    1 trial

  10. Amlodipine

    First Tracks Biotherapeutics

    Sleep Apnea Syndrome

    phase 3 small molecule active

    1 trial

  11. Azacitidine Combined With Venetoclax and ATRA group

    First Tracks Biotherapeutics

    Acute Myeloid Leukemia

    phase 3 small molecule active

    1 trial

  12. Azathioprine

    First Tracks Biotherapeutics

    Myasthenia Gravis

    phase 3 small molecule completed

    1 trial

  13. Bedaquiline (B)

    First Tracks Biotherapeutics

    Pulmonary Tuberculosis

    phase 3 small molecule active

    1 trial

  14. Botulinum Toxin type A (intradermal / submucosal injection at pain area)

    First Tracks Biotherapeutics

    Trigeminal Neuralgia

    phase 3 small molecule active

    1 trial

  15. Busulfan (BU)

    First Tracks Biotherapeutics

    Primary Central Nervous System Lymphoma

    phase 3 small molecule active

    1 trial

  16. CISPLATIN, INFLIXIMAB, IMFINZI 50 mg/mL concentrate for solution for infusion., GEMCITABINE, MYCOPHENOLATE MOFETIL

    AstraZeneca AB

    First-line patients with advanced biliary tract cancers (BTC)

    phase 3 small molecule active

    1 trial

  17. Camrelizumab

    First Tracks Biotherapeutics

    Esophageal Cancer

    phase 3 small molecule active

    2 trials

  18. Capecitabine monotherapy

    First Tracks Biotherapeutics

    Gastric Cancer

    phase 3 small molecule active

    1 trial

  19. Capecitabine(Aibin)

    First Tracks Biotherapeutics

    Stage III Esophageal Squamous Cell Carcinoma

    phase 3 small molecule active

    1 trial

  20. Chemotherapy

    First Tracks Biotherapeutics

    Acute Lymphoblastic Leukemia

    phase 3 small molecule completed

    1 trial

  21. Chemotherapy

    First Tracks Biotherapeutics

    Endometrial Cancer

    phase 3 small molecule active

    1 trial

  22. Clamp-Crushing technique

    First Tracks Biotherapeutics

    Hepatobiliary Disease

    phase 3 other completed

    1 trial

  23. Continuous Gastrocnemius plane block with ropivacaine

    First Tracks Biotherapeutics

    Foot Ankle Injuries

    phase 3 small molecule active

    1 trial

  24. Crystalline cellulose simple occlusive dressing

    First Tracks Biotherapeutics

    Split-thickness Skin Graft Donor Sites

    phase 3 other completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources